CN100502936C - Chinese medicinal compound preparation for inhibiting tumor and resisting insenescence - Google Patents
Chinese medicinal compound preparation for inhibiting tumor and resisting insenescence Download PDFInfo
- Publication number
- CN100502936C CN100502936C CNB2006101709491A CN200610170949A CN100502936C CN 100502936 C CN100502936 C CN 100502936C CN B2006101709491 A CNB2006101709491 A CN B2006101709491A CN 200610170949 A CN200610170949 A CN 200610170949A CN 100502936 C CN100502936 C CN 100502936C
- Authority
- CN
- China
- Prior art keywords
- bull
- semen
- chinese medicinal
- fructus
- ganoderma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A Chinese medicine for improving immunity, accelerating metabolism, suppressing tumor growth and delaying sanility is prepared from 23 Chinese-medicinal materials including ganoderma, champignon, red sage root, wolfberry fruit, etc.
Description
Technical field
The present invention relates to a kind of compound Chinese medicinal preparation, particularly relate to a kind of inhibition tumor, antidotal compound Chinese medicinal preparation.
Background technology
Tumor is the killer of human health, and statistics shows that the sickness rate of malignant tumor has the gesture that increases in China in recent years.Modern medicine mainly adopts operation, chemotherapy and X-ray therapy to the treatment of malignant tumor, though effectively also all there is obviously deficiency in mitigate the disease, mainly is operative treatment relapse rate height, chemotherapy and radiotherapy can cause damage to the immune system of human body, accelerate patient's aging.At present the treatment of malignant tumor is not still had specific medicament, how to suppress growth of tumor and remain medical circle and making great efforts a difficult problem of capturing.In recent years, Chinese medicine is having certain progress aspect the treatment malignant tumor, the Chinese medicine preparation that a collection of inhibition tumor growth also occurred promptly belongs to this type of as the patent No. for a kind of health product that can suppress tumor cell that ZL97105977.2 provided, but its effect that suppresses tumor is all not ideal enough.Therefore, give full play to the advantage of China's tradition Chinese medicine, seek a kind of very necessity of the good Chinese medicine preparation of tumor effect that suppresses.
Summary of the invention
Purpose of the present invention is exactly at the deficiencies in the prior art, provides a kind of by the acceleration bodies intracellular metabolic, with the enhancing body immunity, thus the compound Chinese medicinal preparation of inhibition tumor growth, delaying human body caducity.
Characteristics of the present invention are that raw material composition and the weight proportion thereof of making this pharmaceutically active ingredient are: Ganoderma 90-110g, Lentinus Edodes 90-110g, Hericium erinaceus (Bull. Ex Fr.) Pers. 55-65g, Agaricus blazei Murrill 55-65g, Volvariella volvacea (Bull.Ex Franch.) Singer 70-90g, Coriolous Dersicolor (Fr.) Quel 70-90g, Auricularia 70-90g, Caulis Bambusae In Taeniam 45-55g, Radix Salviae Miltiorrhizae 25-35g, Fructus Hippophae 45-55g, Fructus Lycii 45-55g, Radix Puerariae 45-55g, Semen Hoveniae 30-40g, Semen Coicis 30-40g, Poria 70-90g, Rhizoma Dioscoreae 45-55g, Herba Cistanches 45-55g, papaw 45-55g, Fructus Amomi Rotundus 30-40g, Semen Cassiae 30-40g, Cortex Cinnamomi 25-35g, Cordyceps mycelium 25-35g, sporoderm-broken Ganoderma spore 25-35g.
The preferred prescription of compound Chinese medicinal preparation of the present invention is that raw material composition and the weight proportion thereof of making this pharmaceutically active ingredient are: Ganoderma 100g, Lentinus Edodes 100g, Hericium erinaceus (Bull. Ex Fr.) Pers. 60g, Agaricus blazei Murrill 60g, Volvariella volvacea (Bull.Ex Franch.) Singer 80g, Coriolous Dersicolor (Fr.) Quel 80g, Auricularia 80g, Caulis Bambusae In Taeniam 50g, Radix Salviae Miltiorrhizae 30g, Fructus Hippophae 50g, Fructus Lycii 50g, Radix Puerariae 50g, Semen Hoveniae 35g, Semen Coicis 35g, Poria 80g, Rhizoma Dioscoreae 50g, Herba Cistanches 50g, papaw 50g, Fructus Amomi Rotundus 35g, Semen Cassiae 35g, Cortex Cinnamomi 30g, Cordyceps mycelium 30g, sporoderm-broken Ganoderma spore 30g.
The preparation method of compound Chinese medicinal preparation of the present invention is: get Ganoderma, Lentinus Edodes, Hericium erinaceus (Bull. Ex Fr.) Pers., Agaricus blazei Murrill, Volvariella volvacea (Bull.Ex Franch.) Singer, Coriolous Dersicolor (Fr.) Quel, Auricularia, Caulis Bambusae In Taeniam, Radix Salviae Miltiorrhizae, Fructus Hippophae, Fructus Lycii, Radix Puerariae, Semen Hoveniae, Semen Coicis, Poria, Rhizoma Dioscoreae, Herba Cistanches, papaw, Fructus Amomi Rotundus, Semen Cassiae, Cortex Cinnamomi by above-mentioned weight proportion and adopt water to put forward the back spray drying or drying under reduced pressure is made powder, be mixed in proportion the back preparation with Cordyceps mycelium and sporoderm-broken Ganoderma spore again.Its dosage form way is routinely made capsule, tablet, pill, granule or oral liquid.
Medicine of the present invention is a pure Chinese medicinal preparation, and the prescription compatibility is rigorous, and is without any side effects to the patient, and drug cost is low.Through clinical observation for many years, its effective ingredient can the acceleration bodies intracellular metabolic, strengthens the human body immunity, suppresses tumor growth and prevents oncogene mutation, delaying human body caducity.
Medicine of the present invention carries out system's clinical observation through Weifang City tumour hospital to 240 routine malignant tumor patients, and test group is taken medicine of the present invention on the basis of conventional therapy, and using method is day clothes 3 times.Matched group is treated according to a conventional method.Observed 3 months, one month is a course of treatment, totally 3 courses of treatment.Clinical test results such as following table:
Table 1: take medicine of the present invention and the observation of curative effect of not taking medicine of the present invention
Test statistics shows: combine with conventional treatments with medicine of the present invention 140 routine malignant tumor patients are done clinical treatment test, that obtains significant curative effect accounts for 86%, is much higher than matched group, improvement account for 10%, invalid accounts for 4%, total effective rate reaches 94%.Illustrate that curative effect of medication of the present invention is remarkable, clinical expansion use value is arranged.
The specific embodiment
Embodiment 1:
Make this inhibition tumor, antidotal compound Chinese medicinal preparation raw materials of effective components is formed and weight proportion is: Ganoderma 90g, Lentinus Edodes 110g, Hericium erinaceus (Bull. Ex Fr.) Pers. 55g, Agaricus blazei Murrill 65g, Volvariella volvacea (Bull.Ex Franch.) Singer 70g, Coriolous Dersicolor (Fr.) Quel 90g, Auricularia 70g, Caulis Bambusae In Taeniam 55g, Radix Salviae Miltiorrhizae 25g, Fructus Hippophae 55g, Fructus Lycii 45g, Radix Puerariae 55g, Semen Hoveniae 30g, Semen Coicis 40g, Poria 70g, Rhizoma Dioscoreae 55g, Herba Cistanches 45g, papaw 55g, Fructus Amomi Rotundus 30g, Semen Cassiae 40g, Cortex Cinnamomi 25g, Cordyceps mycelium 35g, sporoderm-broken Ganoderma spore 25g.
Embodiment 2:
Raw material composition and the weight proportion thereof of making this pharmaceutically active ingredient are: Ganoderma 110g, Lentinus Edodes 90g, Hericium erinaceus (Bull. Ex Fr.) Pers. 65g, Agaricus blazei Murrill 55g, Volvariella volvacea (Bull.Ex Franch.) Singer 90g, Coriolous Dersicolor (Fr.) Quel 70g, Auricularia 90g, Caulis Bambusae In Taeniam 45g, Radix Salviae Miltiorrhizae 35g, Fructus Hippophae 45g, Fructus Lycii 55g, Radix Puerariae 45g, Semen Hoveniae 40g, Semen Coicis 30g, Poria 90g, Rhizoma Dioscoreae 45g, Herba Cistanches 55g, papaw 45g, Fructus Amomi Rotundus 40g, Semen Cassiae 30g, Cortex Cinnamomi 35g, Cordyceps mycelium 25g, sporoderm-broken Ganoderma spore 35g.
Embodiment 3:
This suppresses the preparation method of tumor, antidotal compound Chinese medicinal preparation, get Ganoderma 100g, Lentinus Edodes 100g, Hericium erinaceus (Bull. Ex Fr.) Pers. 60g, Agaricus blazei Murrill 60g, Volvariella volvacea (Bull.Ex Franch.) Singer 80g, Coriolous Dersicolor (Fr.) Quel 80g, Auricularia 80g, Caulis Bambusae In Taeniam 50g, Radix Salviae Miltiorrhizae 30g, Fructus Hippophae 50g, Fructus Lycii 50g, Radix Puerariae 50g, Semen Hoveniae 35g, Semen Coicis 35g, Poria 80g, Rhizoma Dioscoreae 50g, Herba Cistanches 50g, papaw 50g, Fructus Amomi Rotundus 35g, Semen Cassiae 35g, Cortex Cinnamomi 30g, spray drying or drying under reduced pressure are made powder after adopting water to carry, and mix the back preparation again with Cordyceps mycelium 30g, sporoderm-broken Ganoderma spore 30g.Its dosage form way is routinely made capsule, tablet, pill, granule or oral liquid.
Claims (2)
1, a kind of inhibition tumor, antidotal compound Chinese medicinal preparation is characterized in that raw material composition and the weight proportion thereof of making this pharmaceutically active ingredient are: Ganoderma 90-110g, Lentinus Edodes 90-110g, Hericium erinaceus (Bull. Ex Fr.) Pers. 55-65g, Agaricus blazei Murrill 55-65g, Volvariella volvacea (Bull.Ex Franch.) Singer 70-90g, Coriolous Dersicolor (Fr.) Quel 70-90g, Auricularia 70-90g, Caulis Bambusae In Taeniam 45-55g, Radix Salviae Miltiorrhizae 25-35g, Fructus Hippophae 45-55g, Fructus Lycii 45-55g, Radix Puerariae 45-55g, Semen Hoveniae 30-40g, Semen Coicis 30-40g, Poria 70-90g, Rhizoma Dioscoreae 45-55g, Herba Cistanches 45-55g, papaw 45-55g, Fructus Amomi Rotundus 30-40g, Semen Cassiae 30-40g, Cortex Cinnamomi 25-35g, Cordyceps mycelium 25-35g, sporoderm-broken Ganoderma spore 25-35g.
2, suppress tumor, antidotal compound Chinese medicinal preparation according to claim 1, it is characterized in that raw material composition and the weight proportion thereof of making this pharmaceutically active ingredient are: Ganoderma 100g, Lentinus Edodes 100g, Hericium erinaceus (Bull. Ex Fr.) Pers. 60g, Agaricus blazei Murrill 60g, Volvariella volvacea (Bull.Ex Franch.) Singer 80g, Coriolous Dersicolor (Fr.) Quel 80g, Auricularia 80g, Caulis Bambusae In Taeniam 50g, Radix Salviae Miltiorrhizae 30g, Fructus Hippophae 50g, Fructus Lycii 50g, Radix Puerariae 50g, Semen Hoveniae 35g, Semen Coicis 35g, Poria 80g, Rhizoma Dioscoreae 50g, Herba Cistanches 50g, papaw 50g, Fructus Amomi Rotundus 35g, Semen Cassiae 35g, Cortex Cinnamomi 30g, Cordyceps mycelium 30g, sporoderm-broken Ganoderma spore 30g.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006101709491A CN100502936C (en) | 2006-12-31 | 2006-12-31 | Chinese medicinal compound preparation for inhibiting tumor and resisting insenescence |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006101709491A CN100502936C (en) | 2006-12-31 | 2006-12-31 | Chinese medicinal compound preparation for inhibiting tumor and resisting insenescence |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN100998819A CN100998819A (en) | 2007-07-18 |
| CN100502936C true CN100502936C (en) | 2009-06-24 |
Family
ID=38257692
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2006101709491A Expired - Fee Related CN100502936C (en) | 2006-12-31 | 2006-12-31 | Chinese medicinal compound preparation for inhibiting tumor and resisting insenescence |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100502936C (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101618050B (en) * | 2009-07-23 | 2011-06-15 | 无限极（中国）有限公司 | Compound fungus polysaccharide with function of enhancing immunity and application thereof |
| CN103393781A (en) * | 2010-06-30 | 2013-11-20 | 杨红宇 | A kind of cardiovascular health medicine |
| CN102008516B (en) * | 2010-12-16 | 2011-12-07 | 刘振钦 | Ultrafine powder traditional Chinese medicine for treating tumors |
| CN103750306B (en) * | 2013-12-31 | 2015-05-20 | 陈慧婷 | Sweet potato stem yam dispersible tablet and preparation method thereof |
| CN104146238B (en) * | 2014-07-11 | 2015-08-05 | 吉林大学 | A kind of have the health food strengthening body immunity function |
| CN105878743A (en) * | 2016-07-07 | 2016-08-24 | 王瑜琳 | Traditional Chinese medicine composition for inhibiting tumors |
| CN107029101B (en) * | 2017-04-26 | 2018-07-20 | 南京益众赢销网络科技有限公司 | A kind of cordyceps sinensis fingered citron oral solution improving immunity |
| CN107961252A (en) * | 2017-12-08 | 2018-04-27 | 芜湖市诺康生物科技有限公司 | A kind of preparation method of ganoderma spove powder capsule |
| CN109363155A (en) * | 2018-11-19 | 2019-02-22 | 武汉市憧憬星元生物科技有限公司 | A kind of wild mushroom function type health care product preparation method and its product |
-
2006
- 2006-12-31 CN CNB2006101709491A patent/CN100502936C/en not_active Expired - Fee Related
Non-Patent Citations (4)
| Title |
|---|
| 东方药膳食疗抗衰老的论析. 陈抗生.药膳食疗，第12期. 2002 |
| 东方药膳食疗抗衰老的论析. 陈抗生.药膳食疗，第12期. 2002 * |
| 限量饮酒及服用解酒液对血液化学成分的影响. 田亚平等.军医进修学院学报，第23卷第2期. 2002 |
| 限量饮酒及服用解酒液对血液化学成分的影响. 田亚平等.军医进修学院学报，第23卷第2期. 2002 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN100998819A (en) | 2007-07-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100502936C (en) | Chinese medicinal compound preparation for inhibiting tumor and resisting insenescence | |
| CN1485083A (en) | Capsule for thyroid cancer / tumor and lymph node | |
| CN1305515C (en) | Chinese medicinal powder and decoction composition for treating cancer | |
| CN101062339A (en) | Medicine for treating diabetes | |
| CN1055638C (en) | Selenium-riched Chinese caterpillar fungus oral liquor and its prepn. method | |
| CN101062221A (en) | Medicine for treating gastric ulcer and duodenal ulcer | |
| CN102872385B (en) | Compound Chinese medicinal composition for treating advanced gastric cancer and preparation method and application thereof | |
| CN110934924A (en) | Traditional Chinese medicine bone marrow hematogenesis composition and application thereof | |
| CN1302799C (en) | Oral Chinese medicinal composition for treating virus myocarditis | |
| CN106511915A (en) | Applications of compound traditional Chinese medicinal composition in preparing medicines for inhibiting skin melanoma lung metastasis | |
| CN1895619A (en) | Chinese-medicinal composition for preventing and treating liver disease and its preparation | |
| CN1879755A (en) | Chinese medicinal composition for preparing tumor-treating medicine | |
| CN102078600A (en) | Anti-cancer compound ganoderma composition, application thereof and pharmaceutical composition containing same | |
| CN1074292C (en) | Cancer treating medicine capsule | |
| CN102205031B (en) | Traditional Chinese medicine for treating male sterility | |
| CN101259180B (en) | A kind of ginseng tongue composition and its preparation method | |
| CN103919845A (en) | Pharmaceutical composition for improving anoxia endurance and preparation method and application thereof | |
| CN104189770A (en) | Pharmaceutical composition for treating tuberculous pleuritis and preparation method thereof | |
| CN103860869A (en) | Traditional Chinese medicine for treating gestational hypertension | |
| CN103893621A (en) | Traditional Chinese medicament for treating senile vaginitis | |
| CN103830651B (en) | Oral cavity fungistat and preparation method thereof | |
| CN1127968C (en) | Oral powder medicine Xiaobaisan for treating leukotrichia and its preparation method | |
| CN1031243C (en) | Medicine for treatment of leukoderma | |
| CN1650943A (en) | A drug for treating hypertension | |
| CN1943756A (en) | A Chinese traditional medicinal composite used for treatment of hypertension and its preparation method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: SHANDONG TIANWANG PHARMACEUTICAL TECHNOLOGY CO., L Free format text: FORMER OWNER: CAI XUWANG Effective date: 20120618 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 261031 WEIFANG, SHANDONG PROVINCE TO: 261061 WEIFANG, SHANDONG PROVINCE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20120618 Address after: 261061, Shandong, Weifang high tech Zone, south of health Street, east of sophomore Road (Biological Medicine Park) Patentee after: SHANDONG TIANWANG PHARMACEUTICAL TECHNOLOGY Co.,Ltd. Address before: 10 building, 261031 building, hi tech Development Zone, Shandong, Weifang Patentee before: Cai Xuwang |
|
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20090624 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |